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The  Socio-Political  Climate
Although  life  expectancy  is currently  at  an all time  high and  our
general health and well-being are better than at any time in our history,
we in Western  societies,  especially in the United  States,  continue  to
worry  about the risks in our lives. We worry a lot about the quality
of our environment  and, particularly in recent years,  we worry  a lot
about our health and well-being. A great deal of concern in the last few
years has been focused on the potential adverse effects on human health
associated with traces  of chemicals  such as pesticides present in our
food and water and, indeed, from time to time the level of concern has
reached paranoic proportions.  The Alar scare of 1989 was a prime ex-
ample  of  this.  Throughout  the  following  discussion  I  will  use  the
pesticide issue as a general case study to illustrate some of the points
I wish to make.
As scientist writer Lewis Thomas has said, it sometimes appears that
we are in danger of becoming "a nation of healthy hypochondriacs,  liv-
ing gingerly and worrying ourselves  half to death."
The fear and worry that exist in a substantial portion  of the public
are very  real. Unfortunately  (or perhaps fortunately),  most of this is
not based  on fact  and most of it seems quite irrational.  As  a society
we seem to have lost our ability to distinguish between serious threats
and those of a quite trivial nature. We smoke billions of cigarettes and
yet we worry ourselves ill over pesticide residues in food and water that,
at very  worst,  constitute risks far lower than those  most of us  face
travelling  to work each day.
The reasons  for all this worry  are many and complex.  They relate,
in part, to the process by which information  is communicated  to the
public (i.e., the media), in part to the characteristics  of the receiver  of
the message (i.e., psychological factors that determine  how we, as in-
dividuals,  perceive  and prioritize risks) and,  in part,  to the nature of
the message  itself (i.e.,  complex scientific  and technical information
often associated with a good deal of genuine  uncertainty).  These  dif-
ficulties are exacerbated by the injection of a wide variety of political
views  and personal  biases and, indeed,  the issues  tend  to become  so
highly  charged and the opposing views  so polarized  that it becomes
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established  fact  from emotional  fancy and political rhetoric.
For quite some time now, the U.S. public has been subjected to a con-
stant barrage of generally bad news on pesticides through the popular
written and electronic media.  Much  of this news is,  of course, tailor-
made to sell newspapers and TV; it is always bad and often sensational
and emotional; there are victims and villains, poignant human interest
stories  combined  with  stories  of  corporate  greed  and  government
ineptness.
The only good news is the fact that the bad news is almost always
highly exaggerated and frequently completely without foundation.  To
be sure, it is possible to find examples of situations in which, as a result
of accident, gross misuse, or negligence, etc., people have been injured
or  even  killed  following  excessive  exposure  to pesticides  and other
chemicals.  Many pesticides are potentially hazardous  to humans and
they must always be used  with caution.  On the other hand,  there is
not one shred of scientific evidence to support claims to the effect that,
in the  general  population,  pesticide  residues  in food  and  water  are
responsible for a multitude of ills ranging from cancer,  birth defects,
reproductive  effects  and immune  dysfunction  (often  referred  to  as
chemical  AIDS) to an increase  in teenage  suicides.
Quite predictably,  this constant negative reinforcement has led to:
1. increased  public  fear  and confusion  over  the  health effects  of
pesticides and the development of strong antipesticide sentiments;
2.  distrust in government regulatory  efforts and increasingly  stri-
dent demands  for more protective  regulation;
3.  increased suspicion of the motives of the agrochemical industry.
This describes the general atmosphere in which many regulatory deci-
sions on pesticides are currently being made  at both the federal and
state levels. As a result of intense public pressure, regulators continu-
ally find themselves  "under the gun" to take further action to obviate
or minimize the perceived health or environmental threats associated
with a pesticide, irrespective of whether action is justified by the scien-
tific evidence available.  Care must be taken to avoid taking overly hasty
action based on incomplete, misleading or erroneous information. Such
actions will not only fail to have the desired health-related effects but
may  well  have  serious  negative  impacts  on  the  agrochemical  and
agricultural  industries.
To the scientists charged with assessing risks and attempting to pro-
vide advice and recommendations on regulatory issues, it is saddening
to realize that the public's perception of the nature and magnitude  of
the health risks associated with pesticides and other chemicals is fre-
quently quite at odds with the available facts. It is also frustrating for
scientists  to  see  that  many  important  legislative  initiatives  and
regulatory decisions  relating to pesticides  are based,  not on science,
but on a variety of political or other nonscientific factors. It often seems
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To understand more clearly some of the frustrations of scientists over
the use, misuse and abuse of science in the regulatory process, we need
to look more carefully at the state-of-the-art  of the science of risk assess-
ment and the role of science in the regulatory decision-making process.
The Regulatory  Process
According to the National Academy of Sciences (NAS), the regulatory
process can be divided into two distinct elements, risk assessment and
risk management. Risk assessment is considered to be a scientific pro-
cess that characterizes the nature of a risk and assesses the probability
of  its occurrence.  Risk  management  is the  process  whereby  an  ap-
propriate regulatory decision is reached on how a given risk can be ob-
viated, minimized or otherwise managed.  Risk management per se is
not a scientific  process.  Obviously, it requires science; but it also  in-
volves a series of value judgments through which the regulator balances
the risks against a variety of other factors (costs, benefits, alternatives,
social  and political considerations)  that depend on the statute under
which regulatory  action  is being contemplated.
Unfortunately,  as we will see, there is often a very fuzzy dividing line
between the processes  of risk assessment and risk management  and
the policy  issues associated  with the latter often have a powerful in-
fluence  over the scientific input into the process.
Toxicologic  Risk
Risk is defined simply as the probability  that an adverse  effect of
some kind will occur. In the case of a chemical  such as a pesticide,  the
potential  risk to human  health is  a  function  of  the toxicity  of  the
material (i.e., its intrinsic capacity to cause an adverse effect such as
neurotoxicity, cancer,  etc.) and the level (intensity and/or duration) of
exposure.
Risk = Toxicity x Exposure
The importance of the level of exposure cannot be overstated  and,
of course,  the fact that the response to any chemical is always related
to the dose, is central to the discipline of toxicology. For many, the very
fact that a pesticide (or pesticide metabolite) is present in food or water,
at any concentration,  is a cause for immediate concern. It must be real-
ized, however, that such pesticide residues are present in extraordinarily
low concentrations,  ususally  measured  in parts per million  (ppm)  or
parts  per billion  (ppb).
A  few  years  ago  we  had  great  difficulty  in  measuring  1 ppm  of
anything.  Now  we routinely  measure ppm and ppb  and occasionally
we can measure ppt (parts per trillion) and ppq (parts per quadrillion).
Our current analytical chemical capabilities are truly amazing and they
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look for.  This has tended to heighten public fears  about the risks of
pesticides in our food and water because it gives many the impression
that we are wallowing in a sea of potentially dangerous chemicals. What
we must remember is that we no longer live in a pristine environment.
If we choose to use pesticides and release them into our environment
and our food supply, we will always be able to measure traces of these
materials  in our food  and water.
The  major problem,  of course,  is not  in detecting  and measuring
pesticide residues in food and water (that's easy and will no doubt get
easier) but in determining what, if any, significance such residues might
have  in terms of adverse effects on human health.  We seem to have
developed the unfortunate habit of making lists of materials  present
in food and water without considering the levels. Regulatory action can-
not be justified simply on the basis of the presence of a given pesticide
in food or water but only after carefully evaluating whether the chemical
represents  a potential health threat.
A careful exposure assessment is a critical component  of any good
risk assessment.
Risk Assessment
The assessment of toxicological risk is the concern of the toxicologist.
The  commonly  accepted  definition of toxicology  - the  science  that
studies  the  adverse  effects  of  chemicals  on  living  organisms  and
assesses  the probability  of their occurrence  - clearly  indicates  risk
assessment  and prediction  as integral components  of the discipline.
There are two ways in which we can evaluate the potential adverse
effects  of chemicals on human  health:
1. We can conduct prospective studies on various surrogate species
(rabbits,  mice,  etc.)  in the laboratory  and hope that we can ex-
trapolate the results to predict the effects likely to occur in man.
2.  We can conduct retrospective epidemiological studies in which we
compare  the health of populations  exposed to a given chemical
against that of similar unexposed  populations.
There are, of course, a great many difficulties  associated with both
methods  and consequently  there is  always a lot of genuine  scientific
uncertainty  in predicting the effect of chemicals  on human health.
Unfortunately, this uncertainty is widely misunderstood.  Most non-
scientists believe we know a lot more about toxicology than we really
do and have very precise and accurate risk assessment capabilities. Con-
sequently, many feel that there is no excuse for not rapidly identifying
chemicals that pose a threat to human health. The media and the public
are also at a loss to understand why the "experts"  frequently disagree
over what appear to be relatively straightforward  issues  and tend to
view this dissension with alarm, suspicion and mistrust. These general
misperceptions have tended to alienate the public from science and have
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pressed by many  scientists.
While there is no question that the science  of toxicology is rapidly
advancing our state of knowledge  and understanding  of the interac-
tions of chemicals with living organisms,  it must be emphasized  that
evaluating human health risks  will always be  an uncertain  process.
Acute  Versus  Chronic Effects
Toxic effects  are usually described as being either acute or chronic.
Acute effects  usually  occur  within  a relatively  short  time (up  to  24
hours) after exposure while the onset of chronic effects such as cancer
or  birth  defects  may  be  delayed  for  years  or  extend  to  future
generations.
The evaluation of acute toxic effects seldom causes serious problems.
The main reason for this is that, for chemicals causing acute toxic ef-
fects,  it is generally  agreed that there  exists a threshold dose  below
which an effect will not occur. Furthermore, this threshold can be deter-
mined experimentally in laboratory animals. In practice, a "no observed
effect  level"  (NOEL) can  be  measured; it is simply the highest  dose
tested at which no adverse effect was observed. The NOEL is a useful
benchmark from which a number of regulatory guidelines, health ad-
visories,  etc.  can  be  derived.  While  there  is  still  some  uncertainty
associated with the extrapolation of acute animal NOELs to humans,
this is usually  acceptable to  all concerned  including the public.
The situation with respect to assessing chronic health effects  such
as cancer is quite different in all respects and is beset by  a good deal
more uncertainty and controversy.  In evaluating acute toxic effects the
objective is to measure the severity of specific  adverse effects in in-
dividual animals; the emphasis is on effects resulting from high doses
for short periods of time. In contrast, cancer risk assessment seeks to
measure increases in the frequency  of occurrence  of a low probability
event  (formation of a tumor) in a population exposed to low  doses of
the chemical  over  a long period of time.
For  statistical  reasons  it  is  simply not  possible  to  obtain  direct
laboratory measures of the low levels of cancer resulting from long-term
exposure of animals to the traces  of pesticides to which humans  are
typically exposed in the real world.  Two ways in which the power  of
the test can  be improved is:
1.  to increase the number  of animals used in the test and
2.  to increase the dose of the test chemical.
There are, of course,  limitations  to the number of animals that can
be used  in routine lifetime  bioassays.  Most tests  employ  about 600
animals  and even  with this number the cost is close  to $1  million.
The  dose  is  more  amenable  to change  and,  as  a result,  the doses
employed in most animal bioassays for carcinogenicity  are high. Indeed,
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approach the so-called "maximum tolerated dose" (MTD), the maximum
dose the animal can withstand. It is assumed that any effects observ-
ed at these high doses can be used to predict  those likely to occur  at
the much lower doses (often ten or one hundred thousand times lower)
of interest with respect to human exposure. This assumption is highly
questionable as are the mathematical  models used in the extrapolation
process.
It is important to recognize that the quantitative estimation of human
cancer risk of necessity involves the extrapolation  of results obtained
under one set of conditions in the laboratory (e.g., rodents exposed to
very high  doses for a lifetime) to predict  those likely  to occur under
another completely different set of conditions in the real world (humans
exposed intermittently  to very low concentrations).
This extrapolation process  across both dose and species  is fraught
with  difficulty  and  uncertainty  and  involves  many  controversial
assumptions  of very  doubtful  scientific  validity. This is the point at
which the policy  aspects  of regulation impinge directly on the scien-
tific input into the risk assessment process. Thus, many of the steps
in cancer risk assessment as practiced by the U.S. Environmental Pro-
tection Agency (EPA), for example, are based entirely on assumptions
and  policy  decisions  that do  not necessarily  reflect  the best  science
available. Wherever there exists an area of uncertainty the EPA steps
in and establishes a guideline (policy assumption) that essentially says
"since we really don't know how to do this we will agree to do it this
way"; the guidelines provide  convenient bridges by which regulators
avoid  areas  of  scientific  uncertainty.  Since,  quite  understandably,
regulators wish  to err only  on the side  of safety  and  prudence,  the
guideline assumptions invariably involve the use of highly conservative
procedures.  Unfortunately, regulators often try to bend scientific truth
to justify and validate  such assumptions.
An assumption with far reaching regulatory consequences  is the one
that holds that, in sharp contrast to the case with acute toxicants, there
is no threshold for carcinogens.  In other words, the only "safe"  dose
of a carcinogen is zero. This causes numerous problems,  one of which
is that, in the United States, carcinogens  are regulated differently from
chemicals  causing  other adverse  effects.  Since,  as discussed earlier,
modern  analytical  instrumentation  allows  us  to find  traces  of  any
chemical we care to look for, we are constantly finding "carcinogens"
that, by definition, constitute a finite level of risk. As a result, we have
been trapped  into playing a rather futile numbers game  in which we
are continually trying to decide what constitutes an acceptable  level
of risk.
The  final  risk  estimates  generated  from cancer  risk  assessments
usually appear as single very precise values  - not, for example,  1 in
a million or even  1.5 in a million, but often  1.53 in a million!  It must
be emphasized  that these represent highly theoretical,  super conser-
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the real world.  Statistically,  even the most frightening values  might
just as easily be zero. Furthermore,  these risk estimates may vary by
up to a millionfold (or more) depending on the assumptions used in the
assessment.  As indicated earlier,  our obsession with generating what
appear to be very precise estimates  of cancer risk is unscientific  and
misleading.  It causes the public to believe that we have exquisitely sen-
sitive test methods and places pressure on regulatory agencies to adopt
increasingly  more stringent  standards.
It is now accepted in the scientific community that cancer is a com-
plex multistage disease that can occur through a number of different
mechanisms.  It is  also widely accepted  that in most, if not  all, cases
there are practical thresholds of exposure below which a carcinogenic
response will not occur.  Consequently,  EPA guidelines  for assessing
carcinogenic risk are currently under review. It is of considerable  con-
cern to scientists that the guidelines are overly inflexible and unable
to change sufficiently rapidly to accommodate new scientific advances.
It is also of fundamental importance to recognize  that the very pro-
cess  we  use  to classify  carcinogens  is based  almost  entirely  on the
results of tests with laboratory animals. There is little, if any, evidence
to suggest that many  of  the chemicals  currently  classified  as  "car-
cinogens" are likely to be "human carcinogens,"particularly  under the
conditions of human exposure.  Here again, our apparent obsession for
making lists of various things comes to the fore and our lists of "car-
cinogens" are always assumed by nonscientists to be lists of "human
carcinogens."
Summary and Future Needs
The foregoing discussion indicates just some of the reasons why scien-
tists often take a somewhat jaundiced view of current risk assessment
procedures (as employed by regulatory agencies). Also, recognition of
the unreasonably high level of conservatism built into the risk estimates
explains, in part, why scientists frequently seem  to take a somewhat
cavalier attitude toward many of the "risky issues" that attain national
prominence.
There is also a feeling among many in the scientific community that
we are not able to distinguish between serious and trivial risks and that
many of our current regulatory priorities are inappropriate. For exam-
ple,  Dr. Bruce Ames of the University  of California in Berkeley  con-
tinues to point out that, of the total human dietary intake of potential
carcinogens,  only  about  0.01  percent  are  synthetic  chemicals  like
pesticides. The rest are naturally occurring products from plants, fungi,
etc.  or materials that are formed during cooking (Ames and Gold). If
Dr. Ames is correct  - and he has widespread support in the scientific
community  - a large proportion  of  our  current  efforts  to identify,
evaluate and regulate the traces of synthetic "carcinogens"  in our food
supply will have little, if any, effect in reducing cancer incidence in the
United States.
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viate situations that represent a significant level of risk, we must clearly
recognize that we have limited resources  available for this purpose. If
these resources are squandered or misdirected along unimportant path-
ways there will be fewer left to apply to more serious issues. It is im-
portant that we direct these precious resources along avenues that pro-
vide the biggest return.
Looking into the future there are three major needs that will improve
the process by which we identify and regulate toxicologic risk and that,
importantly,  will  provide  the  public  with  reassurance  that  the
regulatory system is indeed providing an appropriate level of "safety."
These needs are:
*  To continue to increase our understanding of the basic mechanisms
through which chemicals  exert their potentially  adverse effects
on living organisms;
*  To ensure that regulatory  decisions  are based primarily on the
total weight of scientific evidence available and are influenced as
little  as possible by emotion,  sensationalism  and media-hype;
*  To establish health-based priorities as targets for risk assessment
and possible regulatory  activity;
*  To improve the risk communication process to increase the public's
level  of understanding  of risk and risk assessment.
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